PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)

被引:0
作者
Ansen, S. [1 ]
Schultheis, A. [2 ]
Hellmich, M. [3 ]
Leenders, F. [4 ]
Zander, T. [1 ]
Michels, S. [1 ]
Brockmann, M. [5 ]
Stoelben, E. [6 ]
Groen, H. [7 ,8 ]
Timens, W. [7 ,9 ]
Buettner, R. [2 ]
Thomas, R. K. [4 ]
Perner, S. [10 ]
Wolf, J. [1 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, Ctr Integrated Oncol Koln Bonn, Cologne, Germany
[2] Univ Hosp Cologne, Ctr Integrated Oncol, Inst Pathol, Cologne, Germany
[3] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany
[4] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Dept Translat Genom, D-50931 Cologne, Germany
[5] Hosp Merheim, Dept Pathol, Cologne, Germany
[6] Kliniken Stadt Koln gGmbH, Lungenklin Merheim, Cologne, Germany
[7] Univ Groningen, Groningen, Netherlands
[8] Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands
[9] Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands
[10] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V30
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [31] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
    Singh, G.
    Leong, M.
    Sylvester, S.
    Lee, Y.
    Johnson, C.
    Wu, A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06) : 1006 - 1006
  • [32] PD-L1 expression by RNA-sequencing and survival from pembrolizumab in non-small cell lung cancer (NSCLC)
    Nesline, Mary K.
    Pabla, Sarabjot
    Lee, Yong Hee
    DePietro, Paul
    Early, Amy
    Klein, Roger
    Zhang, Shengle
    Conroy, Jeffrey
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [33] Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study
    Breen, K.
    McCormack, J.
    Fabre, A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S417 - S418
  • [34] Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
    Puig Sanchez, Francisco Guillermo
    Roman Rodriguez, Lucas
    Barca Hernando, Maria
    Marquez Martin, Eduardo
    Romero Romero, Beatriz
    Martin Juan, Jose
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [35] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [36] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    [J]. CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [37] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    [J]. LUNG CANCER, 2020, 147 : 91 - 98
  • [38] Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)
    Kowanetz, Marcin
    Koeppen, Hartmut
    Boe, Marigold
    Chaft, Jamie E.
    Rudin, Charles M.
    Zou, Wei
    Nickles, Dorothee
    Desai, Rupal
    Nakamura, Rin
    Sandler, Alan
    Amler, Lukas
    Hegde, Priti
    Rizvi, Naiyer A.
    Hellmann, Matthew D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
  • [39] Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β
    Hirayama, Aiko
    Tanaka, Kentaro
    Tsutsumi, Hirono
    Nakanishi, Takayuki
    Yamashita, Sho
    Mizusaki, Shun
    Ishii, Yumiko
    Ota, Keiichi
    Yoneshima, Yasuto
    Iwama, Eiji
    Okamoto, Isamu
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] PD-RAD:A translational study investigating PD-L1 expression after radiotherapy for non-small cell lung cancer (NSCLC)
    Kordbacheh, T.
    Chan, C.
    Faivre-Finn, C.
    Franks, K.
    McDonald, F.
    Forster, M.
    Mendes, R.
    Quezade, S.
    Dovedi, S.
    Ralph, C.
    Popat, S.
    Harrington, K.
    Melcher, A.
    Popple, A.
    Illidge, T.
    [J]. LUNG CANCER, 2017, 103 : S78 - S79